upturned mouth, and the flashlight fish (Photoblepharon palpebratus, also known as eyelight fish), with bright headlights that can reach through metres of water, helping the shallowwater predator to hunt at night. If threatened, the fish can also use flashes of light, produced with the help of a mobile shutter working like an eyelid, to confuse its attacker.
Protection from predation is also a widespread ecological benefit of bioluminescence. Many marine species, such as the deepsea hatchet fish (Argyropelecus aculeatus), display on their undersides light mimicking the sunlight falling in from above, thus disrupting their silhouette and deceiving predators approaching from below. This method is also widely used among invertebrates, including the Hawaiian bobtail squid Euprymna scolopes, which has become a valuable
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Shining new light on quorum sensing
Single-cell organisms often are anything but single cells. They co-operate and communicate in multiple and complex ways that science is only beginning to understand. By communicating with each other and acting collectively, they can deliver many complex functions ranging from the bright light in luminescent fish through to the digestion of food in our intestines and also including pathogen invasions. Michael Gross reports. model system for the cooperation of bacterial communities with an animal host.
Bright lights
The symbiosis between the bobtail squid and its luminescent symbiont, the bacterium Vibrio fi sheri (also known as Aliivibrio fi scheri after a recent reclassification), has been studied for almost 30 years now, starting with work from the groups of zoologist Margaret McFall-Ngai and microbiologist Edward Ruby, then at the University of Southern California (PLoS Biol. (2014) 12, e1001783).
It is uniquely suitable for simple model studies because the small, readily breedable squid is transparent as an embryo. Moreover, it is born without the symbiont present, and then selectively admits only the luminescent Vibrio bacteria into its specialised skin cavities that serve as light organs. Remarkably, the cavities include a light sensor to check that the bacteria do their job. Non-luminescent mutants will be found out and removed within a day. The fact that light is the only public good that the bacteria have to produce contributes to making this a very elegant model to stand in for much more complex symbiotic relationships where multiple chemicals are involved, such as the gut microbiome. Genetic manipulation of the symbiont has enabled detailed dissection of the ways in which it influences the development of the host, how the host manages the symbiont, and how both organisms are guided by a shared circadian rhythm. It emerged that both the physiology of the light organ and the lifestyle of its resident bacterial population undergo dramatic changes in the daily cycle, involving eviction of a large part (90%) of the bacteria on a regular basis.
The binary collaboration has also been a valuable system to study how bacteria co-operate with their conspecifics, with the squid offering the rare example of a natural test tube that only hosts one species.
A key aspect of bacterial light production is that the output of a single bacterial cell is costly for the cell itself but insufficient to produce the public good, namely visible light. Thus, it only makes sense for the bacterium to switch on its light production if there is a critical density of its conspecifics around that will do the same thing. This is a key example of the phenomenon of quorum sensing, where a chemical signal emitted by the bacterial species serves as an indication of its own population density and helps to trigger behavioural responses that are only active at high density. This was first recognised in Vibrio fi scheri in the 1980s, after the discovery of the genes luxI for the synthesis of this chemical, the so-called autoinducer, and luxR for the transcription factor that receives the autoinducer signal and responds by activating the luminescence genes.
In the case of V. fi scheri, the autoinducer is N-acyl homoserine lactone (AHL). Some other Gramnegative species have chemically similar signalling molecules. However, the autoinducer 2 takes the more unusual form of a borate ester. It was first discovered in the luminescent bacterium Vibrio harveyi and then found to be used by a wide range of Gram-negative and Gram-positive bacteria, although the enzyme that produces it also serves other physiological roles, such that the presence of its gene is not conclusive evidence of quorum sensing. Pseudomonas uses a quinolone signal molecule. The Gram-positive Staphylococcus aureus, famous for its pathogenic and drug-resistant MRSA strains, by contrast, produces a small cyclic peptide as a quorum-sensing signal.
Following the initial discoveries, quorum sensing was also recognised in pathogenic bacteria, where it helps in switching on pathogenic traits and launching the full-blown attack on the infected organism. In general, quorum sensing can be found in many situations where bacteria occur at high density, including in natural biofilms. Even pathogenic fungi and viruses have come up with similar strategies, as Marvin Whiteley from the Georgia Institute of Technology at Atlanta, USA, and colleagues note in a recent review of quorum sensing (Nature (2017) 551, 313-320).
Intriguingly, however, archaea have been slow to reveal quorumsensing traits. Only a few examples from this domain are known so far, and an understanding of its role in this important domain of life is only beginning to develop, as the group of Brendan Burns at the University of New South Wales at Sydney, Australia, reports in a recent book chapter (in G. Witzany (ed.), Biocommunication of Archaea, Springer (2017) pp 119-132).
Meanwhile, the bobtail squid as a natural test tube for V. fi scheri has already served the study of quorum sensing for decades. Whiteley and colleagues note that it is well suited to answer further questions, such as those concerning the communication between separate aggregates. As the light organ consists of two lobes, each with three different crypts, there are questions to be asked as to whether and how the quorum-sensing mechanism can uphold communications between these bacterial aggregates housed in separate rooms.
Microbial cities
Whereas the bobtail squid light organ is an exceptionally neat example of bacterial co-operation, much of the co-operation happens in a far messier context, such as in biofilms. These occur in a wide range of natural and man-made environments, from the plaque on our teeth to the foundation layer that eventually leads to biofouling on ship hulls and harbour structures. Fossilised stromatolites are monuments to biofilms that proliferated in the early periods of life on Earth, before grazing animals limited the growth of such structures.
Bacteria in biofilms represent a drastically different phenotype from their free-living, planktonic relatives. Like cities, they include both infrastructure (often embedded in a polysaccharide matrix) and social communication. Presumably, quorum Current Biology 27, R1293-R1304, December 18, 2017 R1295 sensing must play an important role in establishing and maintaining a biofilm, but natural examples, while ubiquitous, are difficult to study.
Initial studies of bacterial communication in biofilms typically used laboratory systems such as flow cells, in which the films attach to glass slides that can be directly studied by microscopy. Such studies have revealed important elements of the role of quorum sensing in biofilm formation, as well as benefits that bacteria gain from this lifestyle. Most importantly for medical considerations, biofilms have been found to be more resistant to antimicrobial agents, including widely used antibiotics. To make matters worse, sublethal concentrations of antibiotics, such as those that can be found in the environment due to the widespread use of antibiotics in agriculture (Curr. Biol. (2013) 23, 1063-1065), can encourage some species such as S. aureus to form biofilms, which are then more difficult to eradicate.
Environmental genomics, with its ability to reconstruct and analyse genomes of uncultivated microorganisms on a massive scale, along with other associated -omics techniques, opens up the opportunity to take the study of bacterial communities out of the lab and investigate real-life biofilms as they form in nature.
As Whiteley and colleagues note, studying bacterial communications in the wild will eventually allow for questions of sociobiology to be addressed and for the clarification of issues regarding the precise nature of co-operations between individuals and between species. These questions include the identification of mutualistic, as opposed to parasitic or cheating, relationships, and the evolutionary significance of the communications, which in strict sociobiological terminology are only classified as signals if they evolved to benefit both the sender and the recipient. A communication that evolved for other reasons and is accidentally beneficial to the recipient is then classed as a cue.
As both the advanced methodology of high-throughput studies and the conceptual framework of sociobiology converge on the subject, many more subtleties of the complex communications between bacteria are likely to be found.
Balancing tricks
The most important microbial community whose communications we still don't understand lives in our guts. A healthy human intestine harbours around 10 14 bacteria, and they hold many more genes than our own genome. The obvious use for this symbiont community is in the digestion of nutrients that we cannot break down ourselves, but it also serves as a barrier against pathogenic microbes, and increasing evidence suggests that the gut microbiota are connected to many other physiological functions, including those of our brain.
The complex natural equilibrium in our guts can be disrupted by disease, but also by medical treatments with antibiotics, even if they were targeted at infections elsewhere. Recolonisation of the intestines after treatment with antibiotics can favour the wrong kinds of microbes, such as the notorious Clostridium diffi cile, which can cause life-threatening and untreatable disease.
Understanding how bacteria in the intestines communicate with others of the same and of different species might help to find cures for medical problems, including imbalances after antibiotic treatment. With this in mind, the group of Karina Bivar Xavier at the Gulbenkian Institute of Science at Oeiras, Portugal, manipulated the level of the widely used signalling molecule autoinducer 2 in mice (Cell Rep. (2015) 10, 1861-1871).
The researchers first characterised how the gut microbiota in lab mice were changed by a treatment with the antibiotic streptomycin, and found that it shifts the balance between Firmicutes, which normally comprise the largest population in our gut microbiome, and Bacteroides, a balance that has been linked to health issues including obesity and diabetes. The streptomycin treatment used in the experiments almost eliminated the Firmicutes, such that the Bacteroides came to dominate the gut microbiota.
Then the researchers used Escherichia coli, which naturally both releases and absorbs autoinducer 2, to control the concentration of this molecule in the antibiotic-treated intestines. They produced mutant E. coli strains that were either only producers or only absorbers of the signal molecule and introduced one of these strains in each experiment.
Neither of the mutations had any effect on the viability of E. coli itself. The experiments showed that the mutant that enriches the environment with autoinducer 2 helps the Firmicutes to restore their former role in the microbiota, thus reversing the effect of the antibiotic. In the reverse experiment, depleting autoinducer 2 changed nothing in the situation already unfavourable for Firmicutes.
This simple and elegant experiment in mice shows a way in which malfunctions of the human gut microbiota could perhaps also be treated one day. Currently, the only approach used is the experimental application of fecal transplants to overcome untreatable C. diffi cile infestations.
Nonlethal weapons
Even outside the gut microbiota, the emerging insights into quorum sensing have raised hopes for new treatments. Like the luminescent bacteria switching on their light by quorum, many otherwise harmless bacteria only activate pathogenic phenotypes once they are sufficiently numerous to launch a successful infection. Thus, by interfering with the communication between bacteria, one could perhaps persuade them not to attack.
The group of Alexander Horswill at the University of Colorado at Aurora, USA, has demonstrated this strategy with S. aureus, which in the shape of MRSA is responsible for one of the most widespread and dangerous kinds of hospital infections (Cell Host Microbe (2017 ) https://doi.org/10.1016 /j. chom.2017 . Staphylococci use short cyclic peptides as autoinducers, but different species tend to differ in the peptide sequence they use.
Horswill's group discovered that spent media used to grow Staphylococcus caprae, a commensal bacterium of goats and sheep, contained an agent that inhibits quorum sensing in various strains of S. aureus. Biochemical experiments showed that the autoinducer of S. caprae was the inhibitor, which was then characterised as an eight-residue peptide.
Thus, it appears that the presence of a similar but incompatible signal molecule can block the relevant receptor in S. aureus. To demonstrate the possible medical relevance of this finding, Horswill's group applied the inhibitor in a mouse model of MRSA skin infection and found that it reduced both skin damage and bacterial burden. This has obvious promise for the future treatment of MRSA and other antibiotic-resistant infections, especially in view of the growing threat of antibiotic resistance.
However, Whiteley and colleagues caution that the therapeutic use of quorum sensing, although recognised as a possibility early on, is still quite remote. Other inhibitors of quorum sensing have been found and tested in laboratory systems, but, as the authors note, "we face obstacles on the way from the bench to the clinic".
Beyond the usual difficulties that all drug development efforts face, the authors point to additional problems that result from many unanswered questions in the field. Ranging from uncertainties about how to design a quorum-sensing-based therapy through to concerns around the issue of administering genetically modified microbes to patients, there are still many issues to address.
Valuable experience may be gained from contexts that don't involve human patients. Inhibitors of quorum sensing are already applied to inhibit biofouling in some water treatment plants. Moreover, Whiteley and colleagues argue that the treatment of plant disease would provide a more readily accessible testing ground for such ideas, which could then be translated to animal and human disease.
In an ideal version of the future, treatments that kill off bacteria wholesale, desirable and undesirable ones alike, and possibly encourage the evolution of resistance, could be replaced with non-lethal ones that interfere with bacterial communications, in a kind of propaganda manipulation. Potentially, approaches that suppress virulence rather than killing microbes, may be less likely, or at least slower, to breed resistance. To make this happen, the science of quorum sensing must move beyond the simple systems like the light organs and learn to understand the complex ones like those that we harbour in our bodies.
